← FDA Drug Approvals (Drugs@FDA)
CARMUSTINE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: HENGRUI PHARMA · Approved 2021-03-12
Drug application
- FDA Application #
ANDA211202- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- CARMUSTINE
- Generic name
- CARMUSTINE
- Active ingredients
- CARMUSTINE
- Dosage form
- INJECTABLE
- Route
- INJECTION
- Marketing status
- Discontinued
- Sponsor
- HENGRUI PHARMA
- Manufacturer
- Sandoz Inc.
- First approval
- 2021-03-12
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown